Amedisys, Inc. Profile Avatar - Palmy Investing

Amedisys, Inc.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the ho…
Medical - Care Facilities
US, Baton Rouge [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 0% Bad
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 3.51 1.09 1.05
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -54.54 6.18 13.60
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.92 33.31 32.68
Cash -17.34 3.69 4.47
Capex -37.35 -0.09 -0.06
Free Cash Flow -83.81 -0.29 1.78
Revenue < 0.005 17.49 17.49
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -72.68 0.21 0.75
Operating Margin 53.57 0.09 0.06
ROA -63.95 < 0.005 0.02
ROE -64.16 0.01 0.04
ROIC -40.19 0.02 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AMED is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AMED is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AMED is permitted for members.
End of AMED's Analysis
CIK: 896262 CUSIP: 023436108 ISIN: US0234361089 LEI: - UEI: -
Secondary Listings
AMED has no secondary listings inside our databases.